Related Experiment Video
Updated: Mar 7, 2026

11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
47.6K
Virtual EPID standard phantom audit (VESPA) for remote IMRT and VMAT credentialing
Narges Miri1, Joerg Lehmann1,2,3, Kimberley Legge1
1School of Mathematical and Physical Sciences, The University of Newcastle, Newcastle, Australia.
Physics in Medicine and Biology
|March 2, 2017
Summary
A new virtual audit system (VESPA) enables remote quality assurance for radiation therapy trials. This efficient method streamlines facility credentialing for Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) using electronic portal imaging devices (EPIDs).
Area of Science:
- Medical Physics
- Radiation Oncology
- Clinical Trials Quality Assurance
Background:
- Facility credentialing for clinical trials using Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) traditionally requires resource-intensive on-site audits.
- Remote auditing methods are needed to improve efficiency and accessibility, especially for international facilities.
Purpose of the Study:
- To implement and evaluate a novel virtual Electronic Portal Imaging Device (EPID) standard phantom audit (VESPA) system for remote quality assurance.
- To assess VESPA's effectiveness in supporting facility credentialing for IMRT and VMAT clinical trials.
Main Methods:
- VESPA utilizes published methods and established IMRT quality assurance (QA) procedures, extended for multi-vendor equipment.
- Facilities create treatment plans using provided CT datasets and deliver them to their EPID, along with calibration fields.
- EPID images are uploaded electronically for analysis, involving dose projection into a virtual phantom and 3D/2D gamma analysis.
Main Results:
- Pilot facilities successfully performed data acquisition and upload using VESPA across various planning and delivery systems.
- VESPA offers advantages including fast turnaround, parallel audit capability, efficient international credentialing, extensive data points, and reduced environmental impact.
- Limitations include the lack of absolute dosimetry, necessitating a Level I audit, and reliance on correctly delivered calibration fields.
Conclusions:
- The implemented EPID-based IMRT and VMAT audit system (VESPA) significantly enhances credentialing efficiency for clinical trials.
- VESPA demonstrates potential for wider applications beyond clinical trial credentialing, improving remote QA processes.

